INOVIO PHARMACEUTICALS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
INOVIO PHARMACEUTICALS, INC. (INO) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $222.36 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-03-01
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $222.36M.
- 2021-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $399.67M.
- 2021-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $453.57M.
- 2021-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $508.55M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2022-12-31 | $222.36M 10-K · filed 2023-03-01 |
| 2021-12-31 | $399.67M 10-K · filed 2023-03-01 |
| 2021-09-30 | $453.57M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $508.55M 10-Q · filed 2021-11-09 |
| 2021-03-31 | $581.61M 10-Q · filed 2021-11-09 |
| 2020-12-31 | $461.14M 10-K · filed 2023-03-01 |
| 2020-09-30 | $324.00M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $186.36M 10-Q · filed 2021-11-09 |
| 2020-03-31 | $187.85M 10-Q · filed 2021-11-09 |
| 2019-12-31 | $5.40M 10-K · filed 2023-03-01 |
| 2019-09-30 | $36.12M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $56.48M 10-Q · filed 2020-11-09 |
| 2019-03-31 | $80.97M 10-Q · filed 2020-11-09 |
| 2018-12-31 | $87.03M 10-K · filed 2022-03-01 |
| 2018-09-30 | $103.71M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $111.49M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $113.09M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $142.49M 10-K · filed 2021-03-01 |
| 2017-09-30 | $162.12M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $123.53M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $105.95M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $123.38M 10-K · filed 2020-03-12 |
| 2016-09-30 | $146.98M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $162.09M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $171.22M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $175.93M 10-K · filed 2019-03-12 |
| 2015-09-30 | $193.39M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $180.96M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $103.43M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $111.54M 10-K · filed 2018-03-14 |
| 2014-09-30 | $117.04M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $122.27M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $129.18M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $52.90M 10-K · filed 2017-03-15 |
| 2013-09-30 | $62.22M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $29.67M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $40.42M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $34.86M 10-K · filed 2016-03-14 |
| 2012-09-30 | $31.28M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $36.36M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $40.23M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $47.86M 10-K · filed 2015-03-16 |
| 2011-09-30 | $51.30M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $55.58M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $47.10M 10-K · filed 2014-03-17 |
| 2009-12-31 | $61.18M 10-K · filed 2013-03-18 |
| 2008-12-31 | $19.11M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |